2126

COM:JWTHERAPEUTICS

JW Therapeutics

Stock

Last Close

1.38

22/11 07:59

Market Cap

755.92M

Beta: -

Volume Today

584.90K

Avg: -

Overview Analysis Metrics Financials Filings people API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	-272.62M -	-633.26M 132.29%	-1.66B 162.74%	-702.33M 57.79%	-846.13M 20.48%	-768.00M 9.23%
depreciation and amortization	5.11M -	17.06M 233.88%	23.17M 35.82%	46.33M 99.96%	81.37M 75.63%
deferred income tax		3.43M -	-133.29M 3,983.89%	-60.59M 54.55%	-68.44M 12.96%
stock based compensation		15.44M -	134.25M 769.33%	89.37M 33.43%	82.50M 7.68%	34.97M 57.62%
change in working capital	-195K -	-18.88M 9,579.49%	-955K 94.94%	-28.78M 2,914.03%	-14.06M 51.15%
accounts receivables					-5.30M -
inventory			-955K -	-28.78M 2,914.03%	-8.76M 69.58%
accounts payables
other working capital
other non cash items	161.48M -	427.28M 164.61%	1.38B 222.89%	94.80M 93.13%	228.05M 140.55%	733.03M 221.44%
net cash provided by operating activities	-106.23M -	-188.92M 77.85%	-261.00M 38.15%	-561.20M 115.01%	-536.72M 4.36%
investments in property plant and equipment	-44.15M -	-101.95M 130.92%	-124.24M 21.87%	-73.09M 41.17%	-76.87M 5.18%
acquisitions net			45.31M -
purchases of investments					-23.55M -
sales maturities of investments
other investing activites		-15.61M -	-12.98M 16.84%	-64.04M 393.44%	-23.66M 63.06%
net cash used for investing activites	-44.15M -	-117.55M 166.27%	-91.91M 21.82%	-137.13M 49.20%	-124.08M 9.51%
debt repayment	-2.64M -	-45.30M 1,613.85%	-11.79M 73.96%	-13.02M 10.39%	-115.75M 789.04%
common stock issued			2.14B -	697K 99.97%	94K 86.51%
common stock repurchased
dividends paid
other financing activites	252.47M -	459.35M 81.94%	731.01M 59.14%	-18.30M 102.50%	228.01M 1,346.11%
net cash used provided by financing activities	249.82M -	414.05M 65.74%	2.86B 590.60%	-30.62M 101.07%	112.35M 466.92%
effect of forex changes on cash	13.01M -	13.63M 4.77%	-130.78M 1,059.44%	-67.25M 48.58%	97.39M 244.81%
net change in cash	112.46M -	121.20M 7.77%	2.38B 1,860.13%	-796.20M 133.51%	-451.06M 43.35%
cash at beginning of period	21.20M -	133.66M 530.43%	254.87M 90.68%	2.63B 932.15%	1.83B 30.27%	1.38B 24.59%
cash at end of period	133.66M -	254.87M 90.68%	2.63B 932.15%	1.83B 30.27%	1.38B 24.59%	1.38B 0%
operating cash flow	-106.23M -	-188.92M 77.85%	-261.00M 38.15%	-561.20M 115.01%	-536.72M 4.36%
capital expenditure	-44.15M -	-101.95M 130.92%	-124.24M 21.87%	-73.09M 41.17%	-76.87M 5.18%
free cash flow	-150.37M -	-290.87M 93.43%	-385.24M 32.45%	-634.28M 64.65%	-613.60M 3.26%

All numbers in (except ratios and percentages)